BCFS00633-UNM-Witkiewitz-AUD [Thank You]

Thank you! To complete your submission, please verify your email address and phone number. A message has been sent to your email inbox to complete your email verification. A text will be sent to your phone number to complete your phone verification. Once verified, a member from our study team will contact you within the […]

BCFS00632-UNLV-Flatt-PD [Landing Page]

Apply Now Parkinson’s Research with Inclusion, Diversity and Equity (PRIDE) Four million LGBTQIA+ adults age 50+ live in the U.S. We know very little about the needs of the LGBTQIA+ community living with Parkinson’s disease. This study is working with the LGBTQIA+ community to learn about the health needs of those living with Parkinson’s. Join […]

BCFS00549-CUAnschutz-Thomas-Obesity [Thank You Eligible]

Thank you for completing these questions for basic eligibility for our Time2Eat Time Restricted Eating Weight Loss Study!  Based on your answers it looks like you may be a good candidate for our research study.    If you would like to move forward with our study, please complete our more detailed screening survey and read […]

BCFS00628-UCSD-Feldman-MCI [Thank You – Eligible]

Thank you for completing the VIVA-MIND screening form. A member of our study team will review your information and reach out to you shortly with further details and next steps. If you have any questions, please don’t hesitate to contact us at dodtan@health.ucsd.edu.

BCFS00628-UCSD-Feldman-MCI [Screening Form]

The purpose of this prescreening form is to determine if a person may meet basic eligibility requirements for the VIVA-MIND trial. The VIVA-MIND clinical research trial is coordinated by the Alzheimer’s Disease Cooperative Study (“ADCS) at the University of California, San Diego and is taking place at academic medical centers and Alzheimer’s disease specialty clinics […]

BCFS00628-UCSD-Feldman-MCI [Landing Page]

Apply Now VIVA-MIND A New Alzheimer’s Research Trial Funded by the National Institute on Aging (NIA), and sponsored by Vivoryon Therapeutics, the VIVA-MIND clinical trial is evaluating whether the investigational oral drug varoglutamstat is safe and can slow down or halt the progression of mild Alzheimer’s disease (AD). Join our compensated study today! See If […]